Regeneron Pharmaceuticals (REGN)
CapEx to Revenue
5.60%
Quarterly · Period ending:
REGN CapEx to Revenue
Latest reported5.60%period ending
Latest reported5.60%period ending
REGN Quarterly CapEx/Revenue (0.00% → 5.60%)
Latest values, visible window
High-resolution chart · PNG
REGN capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 5.5982% | |
| 6.396% | |
| 6.4027% | |
| 5.3645% | |
| 4.8101% | |
| 8.9642% | |
| 7.0463% | |
| 4.9346% | |
| 5.9457% | |
| 5.1447% | |
| 9.1285% | |
| 5.2339% | |
| 3.5781% | |
| 5.6355% | |
| 4.4576% | |
| 4.8532% | |
| 5.3759% | |
| 4.7823% | |
| 3.1282% | |
| 3.8577% | |
| 2.8899% | |
| 4.5597% | |
| 6.6614% | |
| 6.6783% | |
| 6.6547% | |
| 9.3042% | |
| 7.4591% | |
| 6.9794% | |
| 5.9957% | |
| 5.4131% | |
| 4.4351% | |
| 6.3841% | |
| 6.9651% | |
| 5.2531% | |
| 6.8019% | |
| 3.9751% | |
| 3.7309% | |
| 3.8257% | |
| 12.2638% | |
| 9.7167% | |
| 11.4492% | |
| 8.6684% | |
| 16.19% | |
| 12.8447% | |
| 24.0225% | |
| 13.1279% | |
| 14.6501% | |
| 10.9907% | |
| 10.6464% | |
| 10.3593% | |
| 11.2999% | |
| 5.3081% | |
| 7.5284% | |
| 4.8225% | |
| 3.657% | |
| 2.3961% | |
| 4.2287% | |
| 4.7694% | |
| 9.1798% | |
| 8.6529% | |
| 13.7872% | |
| 19.7551% | |
| 24.1347% | |
| 20.856% | |
| 19.4855% | |
| 21.9667% | |
| 23.0537% | |
| 19.0124% | |
| 34.159% | |
| 29.2301% | |
| 28.1892% | |
| 14.223% | |
| 11.1157% | |
| 5.4041% | |
| 16.5765% | |
| 21.03% | |
| 8.2316% | |
| 7.5817% | |
| 11.676% | |
| 3.9491% | |
| 1.7655% | |
| 3.5457% | |
| 2.0145% | |
| 10.5965% | |
| 9.3975% | |
| 8.3842% | |
| 2.818% | |
| 6.3364% | |
| 5.4473% | |
| 1.589% | |
| 6.0408% | |
| 19.4687% | |
| 47.294% | |
| 197.356% | |
| 308.8559% | |
| 126.6829% | |
| 123.559% | |
| 80.9553% | |
| 59.0775% | |
| 32.2445% |